Goldman Sachs Group 13F: Cuts Arch Capital (ACGL) Stake by $8.9M

Goldman Sachs Trims Position in Arch Capital Group

Goldman Sachs Group scaled back its investment in Arch Capital Group Ltd. ACGL, according to a Form 13F filing filed with the U.S. Securities and Exchange Commission for the period ended May 15, 2026. The major financial institution trimmed its holdings by 3.1%, shedding 90,355 shares during the reporting window. The filing reflects portfolio adjustments made as of that date and may not capture current day-to-day holdings.

Details on the Share Reduction

Before the adjustment, Goldman Sachs owned 2,950,322 shares of the insurance provider. The sale of 90,355 shares left the firm with 2,859,967 shares. Based on market prices around the filing, the remaining stake carried a value of approximately $281.0 million. Institutional investors routinely rebalance large portfolios to manage risk or lock in gains, and this transaction reflects that ongoing process.

Stock Performance and Valuation

Arch Capital Group shares traded hands around $98.25. The stock has moved between a 52-week low of $82.45 and a 52-week high of $107.09. The company has a price-to-earnings ratio of 7.5, indicating how much investors pay for each dollar of earnings based on trailing results. Its 50-day moving average sits at $99.32, while the 200-day moving average rests near $96.29.

Recent Insider Transactions

Insider activity at the company included a transaction reported by John Pasquesi on June 11, 2026. The filing showed an acquisition of 1,006,700 shares alongside a matching disposition of 1,006,700 shares at a price of $0.0, resulting in zero net cash value for the reported transaction dates.

Analysts Set New Price Targets

Wall Street firms have continued adjusting their outlooks for the insurer through October 2026. On October 13, 2026, Morgan Stanley downgraded its stance on the stock to Equal-Weight and lowered its price target to $100.0 from $105.0. Earlier, on October 12, 2026, Wells Fargo maintained an Overweight rating while adjusting its target to $107.0 from $117.0. Keefe, Bruyette & Woods maintained a Market Perform rating on October 12, 2026, setting a target of $95.0. JP Morgan maintained a Neutral rating on October 9, 2026, with a $113.0 target, and Cantor Fitzgerald maintained a Neutral rating on October 7, 2026, with a $105.0 target. Morgan Stanley also maintained an Overweight rating on October 6, 2026, at a $105.0 target. Mizuho maintained a Neutral rating on September 16, 2026, at $100.0, and JP Morgan maintained a Neutral rating on August 11, 2026, with an $118.0 target. Overall, the company carries a consensus buy rating from 19 analysts, with a mean price target of $111.66.

About Arch Capital Group

Arch Capital Group Ltd., headquartered in Pembroke, Bermuda, provides insurance, reinsurance, and mortgage insurance products worldwide. The company operates through three main segments: Insurance, Reinsurance, and Mortgage. Its offerings range from commercial property and casualty lines to specialty reinsurance and primary mortgage insurance.

What to Watch at Arch Capital Group Ltd.

Investors will look ahead to Arch Capital Group's next earnings report, scheduled for October 26, 2026, for updated figures on revenue and profitability. Future 13F filings from institutional managers will also reveal whether other large holders followed Goldman Sachs in trimming their positions.